ClinConnect ClinConnect Logo
Search / Trial NCT05257746

Perioperative and Postoperative Evaluation of Rectal and Urogenital Function in Patients Undergoing Rectal Resection

Launched by TECHNISCHE UNIVERSITÄT DRESDEN · Feb 24, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how rectal surgery affects bowel and urinary functions in patients who are having a specific type of surgery called rectal resection with total mesorectal excision. The goal is to understand how these functions change before and after the surgery and to identify factors that might lead to problems with bladder control or bowel function afterwards. By learning more about these risk factors, doctors hope to improve treatment plans for patients with rectal cancer and help them recover better in the long run.

To participate in this study, you would need to be between the ages of 65 and 74 and scheduled for rectal resection surgery. However, if you have had previous surgery to remove your rectal sphincter or have a stoma (a surgical opening) that has lasted for over a year, you wouldn’t be eligible to join. If you decide to take part, you can expect to be closely monitored around your surgery to gather important information about your recovery and any changes in your bowel and bladder functions. This research could lead to better care and support for patients like you in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing rectal resection with total mesorectal excision
  • Exclusion Criteria:
  • primary or secondary removal of rectal sphincter apparatus
  • patients with enterostomy persisting 12 months after initial rectal resection

About Technische Universität Dresden

Technische Universität Dresden (TU Dresden) is a leading research institution in Germany, renowned for its commitment to advancing scientific knowledge and innovation across various disciplines, including medicine and healthcare. As a clinical trial sponsor, TU Dresden leverages its cutting-edge research facilities and interdisciplinary expertise to facilitate the development of novel therapeutic interventions and improve patient outcomes. The university fosters collaboration among academic, clinical, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in the conduct of clinical research. Through its dedication to excellence and research-driven initiatives, TU Dresden plays a pivotal role in translating scientific discoveries into practical applications that benefit society.

Locations

Dresden, Saxony, Germany

Patients applied

0 patients applied

Trial Officials

Johannes Fritzmann, Dr.

Principal Investigator

Technical University Dresden

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials